Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China
- PMID: 21220768
- PMCID: PMC3060897
- DOI: 10.1093/cid/ciq144
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China
Abstract
Background: Data on risk factors for severe outcomes from 2009 pandemic influenza A (H1N1) virus infection are limited outside of developed countries.
Methods: We reviewed medical charts to collect data from patients hospitalized with laboratory-confirmed 2009 H1N1 infection who were identified across China during the period from September 2009 through February 2010, and we analyzed potential risk factors associated with severe illness (defined as illness requiring intensive care unit admission or resulting in death).
Results: Among 9966 case patients, the prevalence of chronic medical conditions (33% vs 14%), pregnancy (15% vs 7%), or obesity (19% vs 14%) was significantly higher in those patients with severe illness than it was in those with less severe disease. In multivariable analyses, among nonpregnant case patients aged ≥ 2 years, having a chronic medical condition significantly increased the risk of severe outcome among all age groups, and obesity was a risk factor among those <60 years of age. The risk of severe illness among pregnant case patients was significantly higher for those in the second and third trimesters. The risk of severe illness was increased when oseltamivir treatment was initiated ≥ 5 days after illness onset (odds ratio, 1.42; 95% confidence interval, 1.20-1.67). For persons <60 years of age, the prevalence of obesity among case patients with severe illness was significantly greater than it was among those without severe illness or among the general population.
Conclusions: Risk factors for severe 2009 H1N1 illness in China were similar to those observed in developed countries, but there was a lower prevalence of chronic medical conditions and a lower prevalence of obesity. Obesity was a risk factor among case patients < 60 years of age. Early initiation of oseltamivir treatment was most beneficial, and there was an increased risk of severe disease when treatment was started ≥ 5 days after illness onset.
Figures
Similar articles
-
Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada.Influenza Other Respir Viruses. 2011 Jul;5(4):247-55. doi: 10.1111/j.1750-2659.2011.00204.x. Epub 2011 Feb 9. Influenza Other Respir Viruses. 2011. PMID: 21651735 Free PMC article.
-
Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.BMC Infect Dis. 2012 Apr 20;12:97. doi: 10.1186/1471-2334-12-97. BMC Infect Dis. 2012. PMID: 22520743 Free PMC article.
-
Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China.BMC Infect Dis. 2010 May 31;10:145. doi: 10.1186/1471-2334-10-145. BMC Infect Dis. 2010. PMID: 20513239 Free PMC article.
-
Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis.Infect Dis (Lond). 2016 Nov-Dec;48(11-12):813-22. doi: 10.1080/23744235.2016.1201721. Epub 2016 Jul 6. Infect Dis (Lond). 2016. PMID: 27385315 Review.
-
Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.J Antimicrob Chemother. 2011 May;66(5):959-63. doi: 10.1093/jac/dkr090. Epub 2011 Mar 15. J Antimicrob Chemother. 2011. PMID: 21406435 Review.
Cited by
-
Is There a Role for Immunostimulant Bacterial Lysates in the Management of Respiratory Tract Infection?Biomolecules. 2024 Oct 2;14(10):1249. doi: 10.3390/biom14101249. Biomolecules. 2024. PMID: 39456182 Free PMC article. Review.
-
The pathogenesis of influenza in intact alveoli: virion endocytosis and its effects on the lung's air-blood barrier.Front Immunol. 2024 Jan 26;15:1328453. doi: 10.3389/fimmu.2024.1328453. eCollection 2024. Front Immunol. 2024. PMID: 38343548 Free PMC article. Review.
-
The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis.Curr J Neurol. 2023 Jan 5;22(1):23-29. doi: 10.18502/cjn.v22i1.12613. Curr J Neurol. 2023. PMID: 38011335 Free PMC article.
-
Immigrants, health, and the impact of COVID-19: A narrative review.F1000Res. 2023 Nov 20;12:176. doi: 10.12688/f1000research.130085.2. eCollection 2023. F1000Res. 2023. PMID: 37997587 Free PMC article. Review.
-
Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza.Open Forum Infect Dis. 2023 May 10;10(5):ofad254. doi: 10.1093/ofid/ofad254. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37250175 Free PMC article.
References
-
- Transmission dynamics and impact of pandemic influenza A (H1N1) virus. Wkly Epidemiol Rec. 2009;84:481–484. - PubMed
-
- Centers for Disease Control Prevention. 2009–2010. Influenza Season Week 19 ending May 15, 2010. http:// www.cdc.gov/flu/weekly/weeklyarchives2009-2010/weekly19.htm. Accessed 28 September 2010.
-
- Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009;374:2072–2079. - PubMed
-
- Writing Committee of the World Health Organization Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Bautista E, Chotpitayasunondh T, Gao ZC, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–1719. - PubMed
-
- Louie J, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA. 2009;302:1896–1902. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
